Morgan Stanley’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08K | Sell |
927
-1,297
| -58% | -$1.66K | ﹤0.01% | 7422 |
|
|
2025
Q4 | $3.4K | Sell |
2,224
-3,984
| -64% | -$6.89K | ﹤0.01% | 7137 |
|
|
2025
Q3 | $10.6K | Sell |
6,208
-5,447
| -47% | -$17.3K | ﹤0.01% | 6881 |
|
|
2025
Q2 | $38.2K | Sell |
11,655
-336
| -3% | -$1.25K | ﹤0.01% | 6443 |
|
|
2025
Q1 | $33.5K | Buy |
11,991
+3,107
| +35% | +$20.3K | ﹤0.01% | 6406 |
|
|
2024
Q4 | $154K | Buy |
8,884
+8,456
| +1,976% | +$145K | ﹤0.01% | 5879 |
|
|
2024
Q3 | $11.7K | Sell |
428
-92
| -18% | -$2.86K | ﹤0.01% | 6672 |
|
|
2024
Q2 | $21.2K | Sell |
520
-227
| -30% | -$12.5K | ﹤0.01% | 6439 |
|
|
2024
Q1 | $49.8K | Sell |
747
-1,995
| -73% | -$149K | ﹤0.01% | 6215 |
|
|
2023
Q4 | $311K | Buy |
2,742
+1,652
| +152% | +$173K | ﹤0.01% | 5783 |
|
|
2023
Q3 | $198K | Sell |
1,090
-732
| -40% | -$192K | ﹤0.01% | 5578 |
|
|
2023
Q2 | $667K | Sell |
1,822
-3,120
| -63% | -$1.41M | ﹤0.01% | 5068 |
|
|
2023
Q1 | $3.29M | Sell |
4,942
-436
| -8% | -$387K | ﹤0.01% | 4116 |
|
|
2022
Q4 | $4.71M | Sell |
5,378
-195
| -3% | -$245K | ﹤0.01% | 3808 |
|
|
2022
Q3 | $6.12M | Buy |
5,573
+522
| +10% | +$690K | ﹤0.01% | 3499 |
|
|
2022
Q2 | $4.18M | Buy |
5,051
+1,653
| +49% | +$1.7M | ﹤0.01% | 3919 |
|
|
2022
Q1 | $5.26M | Buy |
3,398
+799
| +31% | +$1.08M | ﹤0.01% | 3632 |
|
|
2021
Q4 | $4.66M | Buy |
2,599
+1,446
| +125% | +$3.87M | ﹤0.01% | 3792 |
|
|
2021
Q3 | $3.81M | Sell |
1,153
-1,627
| -59% | -$5.69M | ﹤0.01% | 4001 |
|
|
2021
Q2 | $12.2M | Buy |
2,780
+2,411
| +653% | +$9.52M | ﹤0.01% | 2759 |
|
|
2021
Q1 | $1.79M | Buy |
369
+365
| +9,125% | +$2.06M | ﹤0.01% | 4345 |
|
|
2020
Q4 | $8K | Buy |
+4
| New | +$1.5K | ﹤0.01% | 6684 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$388 | – | 6729 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6600 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6569 |
|
|
2019
Q4 | $0 | Sell |
1
-1
| -50% | -$585 | ﹤0.01% | 6648 |
|
|
2019
Q3 | $1K | Buy |
2
+1
| +100% | +$1.09K | ﹤0.01% | 6531 |
|
|
2019
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 6518 |
|
|
2019
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 6441 |
|
|
2018
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6407 |
|
|
2018
Q3 | $2K | Buy |
+1
| New | +$4.26K | ﹤0.01% | 6560 |
|
Other funds holding BNGO
GCP
CAM
VCM
VFT
TSS
VF
Morgan Stanley's BNGO Position: Q1 2026 in Review
Morgan Stanley reduced its Bionano Genomics (BNGO) stake by 58% in Q1 2026, selling an estimated $1.66K and leaving 927 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #7422.
Morgan Stanley first reported a position in BNGO in Q3 2018 and has held it in 30 quarters since. The position peaked at $12.2M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.
- Morgan Stanley held 927 shares of Bionano Genomics worth $1.08K as of Q1 2026.
- Morgan Stanley sold 1,297 Bionano Genomics shares in Q1 2026, an estimated $1.66K.
- Bionano Genomics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7422 holding.
- Morgan Stanley first reported a position in Bionano Genomics in Q3 2018 and has held it in 30 quarters since.
- Morgan Stanley's Bionano Genomics position peaked at $12.2M in Q2 2021.
- 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.